Market Place
Sourcing Support
Centocor`s Biologic Stelara Receives Approval in US
01 Apr 2025 //
FDA
Janseen Biotech`s Biologic Stelara Receives Approval in US
01 Apr 2025 //
FDA
Bio-Thera, Dr. Reddy`s sign exclusive deal for Stelara and Simpon
28 Mar 2025 //
PRESS RELEASE
Celltrion`s STEQEYMA® (ustekinumab-stba) in Costco Program
27 Mar 2025 //
PR NEWSWIRE
Sandoz`s Biologic Imuldosa Receives Suppl Approval in US
17 Mar 2025 //
FDA
Lumicera Secures Purchase Agreement for Stelara Biosimilar
13 Mar 2025 //
BUSINESSWIRE
Steqeyma, A Stelara Biosimilar, Now Available In The US
12 Mar 2025 //
PR NEWSWIRE
Biocon`s Yesintek Ph3 Data Shows Efficacy In Plaque Psoriasis
07 Mar 2025 //
PR NEWSWIRE
Fresenius Launches Otulfi (Ustekinumab-aauz) in U.S.
03 Mar 2025 //
BUSINESSWIRE
SmithRx Adds Stelara Biosimilars To Autoimmune Program, Saving $14.5M
28 Feb 2025 //
BUSINESSWIRE
J&J sues Samsung Bioepis over contract breach for Stelara
27 Feb 2025 //
REUTERS
MedImpact Expands Access to Two Biosimilars for Stelara
26 Feb 2025 //
BUSINESSWIRE
Biocon Biologics launches Yesintek Biosimilar to Stelara in US
25 Feb 2025 //
INDPHARMAPOST
Samsung Bioepis Launches PYZCHIVA, Stelara Biosimilar In U.S.
24 Feb 2025 //
BUSINESSWIRE
Sandoz launches biosimilar Pyzchiva in the US
24 Feb 2025 //
GLOBENEWSWIRE
Europe approves Biocon Biologics` Ustekinumab Biosimilar
22 Feb 2025 //
INDPHARMAPOST
Formycon Presents Ustekinumab Biosimilar FYB202 Data at ECCO
20 Feb 2025 //
PHARMAWEB
J&J upholds sales growth confidence as Stelara biosims file in
24 Jan 2025 //
FIERCE PHARMA
Japan Health Authority approves Biocon Ustekinumab BS
09 Jan 2025 //
INDIANPHARMAPOST
Bio-Thera with Tabuk to Commercialize Stelara in Saudi Arabia
26 Dec 2024 //
PRNEWSWIRE
Dong-A ST Secures European Approval for Stelara Biosimilar IMULDOSA
19 Dec 2024 //
BUSINESSWIRE
FDA approves Celltrion`s Steqeyma, a biosimilar to Stelara
18 Dec 2024 //
PRNEWSWIRE
Celltrion`s Biologic Stqeyma Receives Suppl Approval in US
17 Dec 2024 //
FDA
Accord Healthcare Receives Positive CHMP Opinion for Imuldosa
19 Oct 2024 //
PR NEWSWIRE
Alvotech`s Biologic Selarsi (Ustekinumab) Receives Approval in US
18 Oct 2024 //
FDA
Lilly reports Ph 3 study of mirikizumab compared to ustekinumab for Crohn
15 Oct 2024 //
PR NEWSWIRE
US FDA Approves Dong-A ST’s Imuldosa, a Biosimilar to Stelara
11 Oct 2024 //
BUSINESSWIRE
Accord`s Biologic Imuldosa (Ustekinumab) Receives Suppl Approval in US
10 Oct 2024 //
FDA
Fresenius & Formycon Receive FDA Approval For Biosimilar Otulfi
30 Sep 2024 //
BUSINESSWIRE
Fresenius Kabi`s Biologic Otulfi (Ustekinumab) Receives Approval in US
27 Sep 2024 //
FDA
Samsung Bioepis`s Eksunbi (ustekinumab) Receives Approval in Europe
12 Sep 2024 //
EMA
Celltrion`s Steqeyma (ustekinumab) Receives Approval in Europe
11 Sep 2024 //
EMA
EC Approves Celltrion`s SteQeyma For Multiple Inflammatory Diseases
26 Aug 2024 //
BUSINESSWIRE
Teva Reports Strong Q2 Growth, Raises 2024 Guidance
31 Jul 2024 //
GLOBENEWSWIRE
Sandoz Launches Biosimilar Pyzchiva For Chronic Inflammatory Diseases
24 Jul 2024 //
GLOBENEWSWIRE
STADA And Alvotech Launch Uzpruvo, First Ustekinumab Biosimilar In Europe
23 Jul 2024 //
PHARMABIZ
STADA And Alvotech Launch Uzpruvo, First Ustekinumab Biosimilar In EU
22 Jul 2024 //
GLOBENEWSWIRE
Amgen`s Wezenla (ustekinumab) Receives Approval in Europe
18 Jul 2024 //
EMA
J&J beats Wall St estimates on strong drug sales ahead of Stelara competition
18 Jul 2024 //
REUTERS
Samsung Bioepis’ PYZCHIVA Approved by FDA as Biosimilar of Stelara
01 Jul 2024 //
CONTRACT PHARMA
FDA approves biosimilar Pyzchiva (Ustekinumab-ttwe), to be commercialized in US
01 Jul 2024 //
GLOBENEWSWIRE
FDA Approves PYZCHIVA® (ustekinumab-ttwe), Samsung Bioepis’ Biosimilar
01 Jul 2024 //
GLOBENEWSWIRE
TREMFYA Studies Show Potential For SC And IV Induction As IL-23 Inhibitor
20 Jun 2024 //
PR NEWSWIRE
Alvotech and STADA add to strategic alliance through denosumab partnership
12 Jun 2024 //
PRESS RELEASE
Colorado drug review board finds J&J`s Stelara unaffordable
11 Jun 2024 //
FIERCE PHARMA
Rani Oral Biosimilar Ustekinumab Data At DDW 2024
09 May 2024 //
GLOBENEWSWIRE
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
08 May 2024 //
REUTERS
Sandoz`s Ustekinumab Biosimilar Pyzchiva Approved In EU
22 Apr 2024 //
GLOBENEWSWIRE
Alvotech and Teva gain FDA approval of Selarsdi for psoriasis
17 Apr 2024 //
PHARMACEUTICAL TECHNOLOGY
Alvotech USA`s Biologic Selarsdi (ustekinumab-aekn) Receives Approval In US
16 Apr 2024 //
FDA
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™
16 Apr 2024 //
BUSINESSWIRE
Centocor`s Biologic Stelara (ustekinumab) Receives Approval in the U.S.
18 Mar 2024 //
FDA
Janssen-Cilag`s Biologic Stelara (ustekinumab) Receives Approval in the U.S.
18 Mar 2024 //
FDA
Biocon Biologics gears up to challenge Stelara in the US
29 Feb 2024 //
FIERCE PHARMA
Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar
15 Feb 2024 //
GLOBENEWSWIRE
J&J profit edges past Street view after deals delay Stelara competition
24 Jan 2024 //
REUTERS
STADA and Alvotech Secure Approval for Uzpruvo
10 Jan 2024 //
GLOBENEWSWIRE
FDA Accepts for Review BLA for DMB-3115 of Dong-A ST
05 Jan 2024 //
BUSINESSWIRE
J&J, Samsung Bioepis ink Stelara biosimilar settlement
30 Nov 2023 //
FIERCE PHARMA
